SCHEMBL26066699

SCHEMBL26066699

NCc1cn(CCC(=O)NCCO)nn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 3/20 0.43
▸ CSNK2A1 P68400 1/20 0.43
▸ FOLH1 Q04609 5/20 0.39
▸ HDAC3 O15379 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC7 Q8WUI4 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ HDAC10 Q969S8 1/20 0.39
▸ HDAC11 Q96DB2 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ HDAC9 Q9UKV0 1/20 0.39
▸ HDAC5 Q9UQL6 1/20 0.39
▸ NCOR2 Q9Y618 1/20 0.39
▸ MAOA P21397 2/20 0.36
▸ MAOB P27338 2/20 0.36
▸ GLS O94925 1/20 0.36
▸ LMNA P02545 1/20 0.35
▸ GBA1 P04062 2/20 0.35
▸ TNKS O95271 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26066647 0.86 FOLH1 (0.42) FOLH1MAOAMAOBLMNAFNTA
SCHEMBL26066667 0.84 HDAC1 (0.40) HDAC1CSNK2A1FOLH1HDAC3HDAC4
SCHEMBL26066670 0.80 HDAC1 (0.40) HDAC1CSNK2A1FOLH1HDAC3HDAC4
SCHEMBL25013968 0.79 FOLH1 (0.46) HDAC1FOLH1HDAC3HDAC4HDAC7
SCHEMBL12436745 0.78 CSNK2A1 (0.43) HDAC1CSNK2A1FOLH1MAOAMAOB
SCHEMBL12825187 0.77 MAOA (0.42) MAOAMAOBGBA1
SCHEMBL25938475 0.76 DNM1 (0.44) HDAC1CSNK2A1FOLH1HDAC3HDAC4
SCHEMBL23876336 0.75 MAOA (0.38) HDAC1CSNK2A1FOLH1HDAC3HDAC4
SCHEMBL25013920 0.75 GBA1 (0.43) MAOAGLSGBA1
SCHEMBL23736423 0.75 HDAC1 (0.48) HDAC1CSNK2A1FOLH1LMNAGBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154344-A1 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-08-17 — — WO disclosed
Send feedback